Esther de Rooij

The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus

Tineke Kraaij, Sylvia W.A. Kamerling, Esther de Rooij et al. · Journal of Autoimmunity · 2018 · 155 citations · Full text

Rheumatology, Autoimmune Disease, Lupus +8

Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215

Jaap Goudsmit, Anthony de Ronde, Esther de Rooij et al. · Journal of Virology · 1997 · 124 citations · Full text

Primary Immunodeficiency, Viral Evolution, Vivo Fitness +15

Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant Virus

Anthony de Ronde, Maaike van Dooren, Lia van der Hoek et al. · Journal of Virology · 2001 · 121 citations · Full text

Viral Replication, Immunology, Immunodominance +21

Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O

Michel P. de Baar, Maaike W. van Dooren, Esther de Rooij et al. · Journal of Clinical Microbiology · 2001 · 76 citations · Full text

One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG

Michel P. de Baar, Eveline C. Timmermans, Margreet Bakker et al. · Journal of Clinical Microbiology · 2001 · 55 citations · Full text